1992
DOI: 10.1113/jphysiol.1992.sp019081
|View full text |Cite
|
Sign up to set email alerts
|

Effects of NG‐nitro‐L‐arginine and L‐arginine on regional cerebral blood flow in the cat.

Abstract: 1. We studied the effects of NG-nitro-L-arginine (NOLA), a potent inhibitor of the L-arginine-nitric oxide pathway, and L-arginine, the precursor of nitric oxide, on regional cerebral blood flow, electrocortical activity and ex vivo cerebrovascular reactivity in the cat. Flow was measured via radiolabelled microspheres, and vascular responses were studied by measuring isometric tension of isolated middle cerebral arterial rings. 2. NOLA (30 mg kg-1 bolus followed by 1 mg kg-1 min-1 infusion) caused an approxim… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
40
0
1

Year Published

1993
1993
2010
2010

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 126 publications
(45 citation statements)
references
References 37 publications
(65 reference statements)
4
40
0
1
Order By: Relevance
“…As L-NAME has proved to be a potent inhibitor of nitric oxide production (Moore et al, 1990;Rees et al, 1990), and the observed effects of this Control substance were reversed by L-arginine, precursor of endothelial nitric oxide synthesis (Ignarro, 1990; al.,1991a), our results suggest that the reduction in cerebral blood flow by L-NAME is due to decreases in basal nitric oxide production and, consequently, to inhibition of nitric oxide-mediated basal vasodilator tone in the cerebral vasculature under normal conditions. This is in line with observations by others in the cerebral blood flow of anaesthetized animals (Gardiner et al, 1991b;Kovach et al,1992;Kozniewska et al, 1992;Pellegrino et al, 1992) and supports the idea that an important basal vasodilator tone mediated by nitric oxide is present in the cerebral circulation as in other vascular beds (Moncada et al, 1991a). Systemic hypertension and bradycardia have been previously observed with nitric oxide inhibitors (Moncada & Higgs, 1990).…”
Section: Discussionsupporting
confidence: 79%
“…As L-NAME has proved to be a potent inhibitor of nitric oxide production (Moore et al, 1990;Rees et al, 1990), and the observed effects of this Control substance were reversed by L-arginine, precursor of endothelial nitric oxide synthesis (Ignarro, 1990; al.,1991a), our results suggest that the reduction in cerebral blood flow by L-NAME is due to decreases in basal nitric oxide production and, consequently, to inhibition of nitric oxide-mediated basal vasodilator tone in the cerebral vasculature under normal conditions. This is in line with observations by others in the cerebral blood flow of anaesthetized animals (Gardiner et al, 1991b;Kovach et al,1992;Kozniewska et al, 1992;Pellegrino et al, 1992) and supports the idea that an important basal vasodilator tone mediated by nitric oxide is present in the cerebral circulation as in other vascular beds (Moncada et al, 1991a). Systemic hypertension and bradycardia have been previously observed with nitric oxide inhibitors (Moncada & Higgs, 1990).…”
Section: Discussionsupporting
confidence: 79%
“…2A and B). This observation is consistent with our previous report in cats (Kovách et al, 1992) and indicates that L-arginine availability is not a rate-limiting factor of the resting NO production. L-Arginine, however, was shown to reverse L-NAME-induced cerebrovascular NOS-inhibition in a previous study (Sándor et al, 1994), and therefore we analyzed its effect also in chronically L-NAME pretreated animals (n=12).…”
Section: Resultssupporting
confidence: 83%
“…This conclusion is not obvious since the constitutive NOS activity of the hypothalamus is only reduced by approximately 90% during chronic oral L-NAME treatment (Benyó et al, 1995). Taken into account that in case of diminished NO production the cerebrovascular reactivity to NO increases (Kovách et al, 1992;Moncada et al, 1991), the remnant 10% NOS activity could contribute significantly to the maintenance of the cerebral blood flow. Indeed, acute L-NAME treatment was shown to reduce the blood flow in the neocortex, hippocampus and striatum of rats subjected to chronic NOS blockade (Kelly et al, 1995), indicating that the remnant NO production contributes to the maintenance of the blood flow in these brain regions.…”
Section: Discussionmentioning
confidence: 91%
“…NO synthase inhibition results in a significant re duction of the steady-state rCBF values not only after L-NAME administration, but also following � -nitro-L-arginine treatment, as was shown by Kovach et al (1992) in the same species under the same anesthesia. The question arises of whether the regional differences in the steady-state rCBF and rSBF values following L-NAME administration may determine in some way the extent of the re duction of the CO2 responsiveness in those regions.…”
Section: Discussionmentioning
confidence: 73%